To determine potential cross-talk among TET2 and other epigenetic modulators, we examined the RNA-seq results of TET2 knockout HCC cells and found that among diverse epigenetic factors, KMT2D and ARID1A are strikingly decreased upon deletion of TET2 (Fig. 1A). The gene discussed is KMT2D; the disease is hepatocellular carcinoma.